Literature DB >> 365175

Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid.

J Hughes, G Mellows.   

Abstract

The mode of action of the antibiotic pseudomonic acid has been studied in Escherichia coli. Pseudomonic acid strongly inhibits protein and RNA synthesis in vivo. The antibiotic had no effect on highly purified DNA-dependent RNA polymerase and showed only a weak inhibitory effect on a poly(U)-directed polyphenylalanine-forming ribosomal preparation. Chloramphenicol reversed inhibition of RNA synthesis in vivo. Pseudomonic acid had little effect on RNA synthesis in a regulatory mutant, E. coli B AS19 RC(rel), whereas protein synthesis was strongly inhibited. In pseudomonic acid-treated cells, increased concentrations of ppGpp, pppGpp and ATP were observed, but the GTP pool size decreased, suggesting that inhibition of RNA synthesis is a consequence of the stringent control mechanism imposed by pseudomonic acid-induced deprivation of an amino acid. Of the 20 common amino acids, only isoleucine reversed the inhibitory effect in vivo. The antibiotic was found to be a powerful inhibitor of isoleucyl-tRNA synthetase both in vivo and in vitro. Of seven other tRNA synthetases assayed, only a weak inhibitory effect on phenylalanyl-tRNA synthetase was observed; this presumably accounted for the weak effect on polyphenylalanine formation in a ribosomal preparation. Pseudomonic acid also significantly de-repressed threonine deaminase and transaminase B activity, but not dihydroxyacid dehydratase (isoleucine-biosynthetic enzymes) by decreasing the supply of aminoacylated tRNA(Ile). Pseudomonic acid is the second naturally occurring inhibitor of bacterial isoleucyl-tRNA synthetase to be discovered, furanomycin being the first.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365175      PMCID: PMC1186229          DOI: 10.1042/bj1760305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid in the acceptor site of ribosomes.

Authors:  W A Haseltine; R Block
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

2.  The control of ribonucleic acid synthesis in Escherichia coli. V. Characterization of a nucleotide associated with the stringent response.

Authors:  M Cashel; B Kalbacher
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

3.  Function of the rel gene in Escherichia coli.

Authors:  Y Sokawa; J Sokawa; Y Kaziro
Journal:  Nat New Biol       Date:  1971-11-03

4.  Threonine deaminase from Escherichia coli: feedback-hypersensitive enzyme from a genetic regulatory mutant.

Authors:  D H Calhoun
Journal:  J Bacteriol       Date:  1976-04       Impact factor: 3.490

5.  Inhibition of leucyl-transfer ribonucleic acid synthetasymol.

Authors:  A Ogilvie; K Wiebauer; W Kersten
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

6.  Isoleucine and valine metabolism of Escherichia coli. XIV. Effect of thiaisoleucine.

Authors:  A Szentirmai; H E Umbarger
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

7.  Influence of side-chain structure of aliphatic amino acids on binding to isoleucyl-tRNA synthetase from Escherichia coli MRE 600.

Authors:  J Flossdorf; H J Prätorius; M R Kula
Journal:  Eur J Biochem       Date:  1976-06-15

8.  Isoleucine and valine metabolism of Escherichia coli. XV. Biochemical properties of mutants resistant to thiaisoleucine.

Authors:  A Szentirmai; M Szentirmai; H E Umbarger
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

9.  Histidine regulation in Salmonella typhimurium. XI. The percentage of transfer RNA His charged in vivo and its relation to the repression of the histidine operon.

Authors:  J A Lewis; B N Ames
Journal:  J Mol Biol       Date:  1972-04-28       Impact factor: 5.469

10.  Isolation and partial characterization of Escherichia coli mutants with altered glycyl transfer ribonucleic acid synthetases.

Authors:  W R Folk; P Berg
Journal:  J Bacteriol       Date:  1970-04       Impact factor: 3.490

View more
  77 in total

1.  mRNA composition and control of bacterial gene expression.

Authors:  S T Liang; Y C Xu; P Dennis; H Bremer
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  Drug target validation: lethal infection blocked by inducible peptide.

Authors:  J Tao; P Wendler; G Connelly; A Lim; J Zhang; M King; T Li; J A Silverman; P R Schimmel; F P Tally
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Catalytic enantioselective diversity-oriented synthesis of a small library of polyhydroxylated pyrans inspired from thiomarinol antibiotics.

Authors:  Raed M Al-Zoubi; Dennis G Hall
Journal:  Mol Divers       Date:  2014-08-24       Impact factor: 2.943

4.  Enzymatic basis of "hybridity" in thiomarinol biosynthesis.

Authors:  Zachary D Dunn; Walter J Wever; Nicoleta J Economou; Albert A Bowers; Bo Li
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-26       Impact factor: 15.336

5.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

Review 6.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.

Authors:  Daniel G Driscoll; Casey L Young; Urs A Ochsner
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 8.  Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Campoli-Richards
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

9.  The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability.

Authors:  Ayome Abibi; Andrew D Ferguson; Paul R Fleming; Ning Gao; Laurel I Hajec; Jun Hu; Valerie A Laganas; David C McKinney; Sarah M McLeod; D Bryan Prince; Adam B Shapiro; Ed T Buurman
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

10.  Reduction of translating ribosomes enables Escherichia coli to maintain elongation rates during slow growth.

Authors:  Xiongfeng Dai; Manlu Zhu; Mya Warren; Rohan Balakrishnan; Vadim Patsalo; Hiroyuki Okano; James R Williamson; Kurt Fredrick; Yi-Ping Wang; Terence Hwa
Journal:  Nat Microbiol       Date:  2016-12-12       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.